Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | VLRS | CRTO |
|---|---|---|
| Price | $6.35 | $14.90 |
| Change today | ▼ 2.31% | ▲ 0.68% |
| Market cap | $729.94M | $730.06M |
| Return, 3 months | -25.1% | -35.6% |
| Return, year to date | -28.5% | -27.7% |
| Return, 1 year | -7.3% | -28.9% |
| P/E (TTM) | -3.9 | 7.6 |
| P/B | 10.7 | 0.6 |
| P/E percentile vs own 5y | 57th | 16th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +24.0% | -11.3% |
| Net profit growth (YoY) | -101.6% | -48.7% |
| Gross margin | 3.9% | 53.6% |
| Operating margin | 0.3% | 8.0% |
| Net margin | -5.7% | 5.6% |
| Return on equity | -117.3% | 9.4% |
| Analyst target vs. price | +81.1% | +42.3% |
| Analyst buy share | 100% | 50% |
| RSI (14) | 39 | 30 |
| 30-day volatility | 34.1% | 27.7% |
| Max drawdown, 1 year | -42.1% | -37.7% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
